Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation
Details : Grape Seed Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prehypertension.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 29, 2025
Lead Product(s) : Grape Seed Extract
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Quercetin Phytosome
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : Thorne HealthTech
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Quercetin on Metabolic Health
Details : Quercetin Phytosome is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 25, 2022
Lead Product(s) : Quercetin Phytosome
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : Thorne HealthTech
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Meriva
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Meriva is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 12, 2021
Lead Product(s) : Meriva
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Artichoke Extract
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : Azienda di Servizi alla Persona di Pavia
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Artichoke Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Insulin Resistance.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
November 05, 2020
Lead Product(s) : Artichoke Extract
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : Azienda di Servizi alla Persona di Pavia
Deal Size : Inapplicable
Deal Type : Inapplicable